Device Trial Radar · NCT00746759
Airway Epithelium Gene Expression: AEGIS IDE
Last checked: Nov 20, 2026Latest source record: Jun 4, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,331
Actual
Start
Feb 2010
Primary completion
Dec 2014
Study completion Feb 2015
Sponsor
- Lead sponsor
- Allegro Diagnostics, Corp.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- University of Pennsylvania; Columbia University; Temple University; Indiana University; University of Alabama at Birmingham; University of Missouri-Columbia; Louisiana State University Health Sciences Center in New Orleans; University of Wisconsin, Madison; Medical University of South Carolina; National Jewish Health; Overlake Hospital Bellevue WA; Pulmonary and Allergy Associates of New Jersey; Pulmonary Associates of Arizona; William Jennings Bryan Dorn VA Medical Center; Virginia Commonwealth University; Jamaica Hospital Medical Center; North Florida/South Georgia Veterans Health System; Steward St. Elizabeth's Medical Center of Boston, Inc.; University of California, Davis; Yale University; The Cleveland Clinic
- First posted
- Sep 4, 2008
Design
- Study type
- Observational
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the research study is to develop a new, more sensitive, and less invasive test for diagnosing lung cancer at an earlier stage, when it can more easily be cured. The investigators hypothesize that certain genes are expressed differently in current and former smokers who have lung cancer, and this difference in gene expression may be a biomarker for lung cancer.
Conditions
- Lung Cancer
Interventions
Biomarker (not used as an intervention)Device
This study is an observational study. There is no intervention.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Lung Cancer Diagnosis (positive or negative)Time frame: 12 months
Locations
21 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama
Birmingham, Alabama
Pulmonary Associates of Arizona
Phoenix, Arizona
University of California- Davis
Sacramento, California
18 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.